category
PNAS
date
Mar 19, 2026
slug
status
Published
summary
首次揭示转谷氨酰胺酶2(TG2)的交联活性是驱动α-突触核蛋白病理形成的核心机制,为突触核蛋白病(如帕金森病)提供了新的治疗靶点。
tags
蛋白质组学
type
Post
📄 原文题目
The cross-linking activity of transglutaminase 2 drives α-Synuclein pathology in synucleinopathy models
🔗 原文链接
💡 AI 核心解读
首次揭示转谷氨酰胺酶2(TG2)的交联活性是驱动α-突触核蛋白病理形成的核心机制,为突触核蛋白病(如帕金森病)提供了新的治疗靶点。
📝 英文原版摘要
Proceedings of the National Academy of Sciences, Volume 123, Issue 12, March 2026. <br />SignificanceTransglutaminase 2 (TG2) has been implicated in common neurodegenerative diseases and particularly in synucleinopathies that include Parkinson’s disease (PD) and dementia with Lewy bodies. However, due to its multidomain and multifunctional ...
- 作者:NotionNext
- 链接:https://tangly1024.com/article/32e48bd6-1f96-81f2-98af-f6c85dc1a47b
- 声明:本文采用 CC BY-NC-SA 4.0 许可协议,转载请注明出处。
相关文章
